Publication: 2648

Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas
      QxMD      Google Scholar   
Citation:
BMC Cancer vol 17 505
Year:
2017
Type:
Manuscript
Funding:
NCTN
Endpoint:
No-Endpoint
Analysis:
Trial-Description-Only
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epub-ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
6
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, U10CA031983, U10CA032291, U10CA180858, U10CA180867, U10 CA032291, U10 CA180821, U10 CA180858, U10 CA180882, P30 CA016058, U10 CA180867  
Corr. Author:
 
Authors:
                                   
Networks:
CA824, IL018, LAPS-MA036, LAPS-MN026, LAPS-NY016, LAPS-OH007, LAPS-TX035, MD015, METROMIN, NORTHWELL, OH070   
Study
Alliance-A021501
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
Pancreatic cancer, Borderline resectable, Pancreatoduodenectomy, Radiation, Stereotactic, Chemotherapy, Clinical trial